In 2022, we invested in biotechnology company Nuritas, based in Dublin, Ireland, and in the US. The company harnesses the power of artificial intelligence and genomics to unlock peptides – the most health benefiting components hidden within plants and natural food sources.

Plant-based peptide products are applied across functional foods in supplements, cosmetics and food ingredients to generate benefits beyond nutrition.

Nuritas has established the world’s largest peptide knowledge base to help replace current unwanted ingredients and molecules with more natural and sustainable alternatives. The platform can identify and develop new bioactives 10 times faster and 500 times more accurately than traditional discovery methods, while significantly reducing costs.